Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Retinal cotton wool spot associated with cladribine therapy for multiple sclerosis. Mult Scler Relat Disord 2021 Feb;48:102661

Date

12/16/2020

Pubmed ID

33321344

DOI

10.1016/j.msard.2020.102661

Scopus ID

2-s2.0-85097757289 (requires institutional sign-in at Scopus site)   1 Citation

Abstract

Cladribine has been shown to lower relapse rates and decrease disease progression in patients with relapsing forms of multiple sclerosis (MS). Reported adverse effects with use of cladribine include lymphopenia, neutropenia, and infections. Ocular complications have not previously been described with cladribine. We report the case of a patient developing visual symptoms and a large retinal cotton wool spot in association with initiation of cladribine therapy.

Author List

Gummi R, Walsh RD, Ahmad B

Authors

Baseer Ahmad MD Associate Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin
Ryan Walsh MD Associate Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Cladribine
Humans
Immunosuppressive Agents
Lymphopenia
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting